Acute coronary syndrome treatment delay in low to middle-income countries: A systematic review

Lemlem Beza1, Sharon L Leslie2, Bekele Alemayehu1

  • 1College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Insights

Prehospital treatment delays significantly worsen acute coronary syndrome (ACS) outcomes in low- to middle-income countries (LMICs). Addressing factors like transportation and rural access is crucial for improving patient survival rates.

Area of Science:

  • Cardiology
  • Public Health
  • Health Systems Research

Background:

  • Acute coronary syndrome (ACS) outcomes are improving in high-income nations but worsening in low- to middle-income countries (LMICs).
  • Prehospital delays in treatment are a primary driver of poor ACS clinical outcomes in LMICs.
  • Understanding factors contributing to these delays is essential for targeted interventions.

Purpose of the Study:

  • To systematically review the literature on prehospital treatment delays for ACS in LMICs.
  • To determine the average time from symptom onset to treatment.
  • To identify sociodemographic, clinical, and health system factors associated with these delays.

Main Methods:

  • A comprehensive systematic review of English-language literature from January 1990 to May 2020.
  • Inclusion of 29 studies meeting predefined criteria.
  • Definition of time to treatment as symptom onset to first medical contact, analyzed in relation to a 12-hour threshold.

Main Results:

  • The mean time from symptom onset to first medical contact was 12.7 hours, with a wide range (10 minutes to 96 hours).
  • Older age, female sex, illiteracy, rural residence, and financial limitations were associated with longer delays.
  • Inadequate emergency transportation systems and poor communication between healthcare facilities were significant contributors.

Conclusions:

  • Prehospital delays in ACS treatment are substantial in LMICs.
  • Sociodemographic and health system factors critically influence treatment access.
  • Interventions targeting these factors are needed to improve ACS outcomes in LMICs.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
58
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
198
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
85
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
83
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
99